As a result of Gavi's immunisation services support, an additional 76.5 million children were immunised between 2001 and 2010
A 2007 review of Gavi’s immunisation services support (ISS) programme said ISS had a “significant, positive impact” on immunisation coverage. The review looked at the first five years of ISS in 53 countries approved for ISS support, and said ISS helped boost coverage in countries with both high and low baseline coverage rates.
Between 2001 and 2010, an extra 76.5 million (WHO projections 2010) children were immunised as a result of ISS.
In 2007, Gavi commissioned an external review of the first five years of its pioneering immunisation services support. Download the final report.
Democratic Republic of Congo
In the Democratic Republic of Congo (DRC), for example, ISS supported a WHO/UNICEF strategy to boost immunisation in low-performing districts, paying for vehicles and transportation, personnel, training, and staff supervision.
After one year, 70 percent of children in these districts (more than half of the country’s 276 health zones) were immunised with three doses of diphtheria-tetanus-pertussis vaccine (DTP3) by their first birthday, compared with 54% in the other districts.
Tanzania’s rural Mpwapwa district also received ISS support. The 280,000 population had not been generally supportive of immunisation, but the district used US$ 13,000 of Tanzania’s ISS funding to educate and sensitise the people.
Once solid support was in place, ISS funds paid for training, fridges, bicycles for outreach, calculators for data collection, and a stock of vaccination cards. Within one year, DTP3 coverage rose and then stayed high.
Please note that this type of Gavi support is being phased out with all cash-based support channelled through health system strengthening.